Associated Medical Professionals - Urology

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials
• Bladder cancer1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1 trial

Running trials

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

  NCT05288166· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

  NCT03706365· Phase 2/3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

  NCT03914794· Phase 2· Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins· Source